Inhibitex prices IPO

Infectious disease play INHX raised $35 million in an IPO through the sale of 5 million shares at $7, giving it a post-money valuation of $122.5 million. Earlier on Thursday, the company reduced its proposed price to $7 from $10-$12 and decreased the proposed shares to 5 million from 5.9 million. Had the company sold 5.9 million shares at $11, it would have raised $64.9 million and been valued at $202.4 million. ...